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Abstract 
Multifunctional nanoparticles have been widely investigated for biomedical applications, such as 
imaging, therapy, and drug delivery. Especially, photoactive nanoparticles have received great 
attention as theranostic agents because of their heat-generating abilities after exposure to laser 
irradiation. However, photostability and safety issues have been the technical hurdles for further 
clinical applications. Here, we designed nitrogen (N)-doped carbon nanodots (N-CNDs) that have 
strong absorption in the near-infrared region, high photostability, and excellent biodegradability. 
Optimized N-CNDs can be utilized not only as a new photoacoustic (PA) imaging agent but also as 
a superior photothermal therapy (PTT) agent in vivo because of their strong optical absorption at 
a specific wavelength. We used N-CNDs to perform in vivo/ex vivo noninvasive PA imaging of 
sentinel lymph nodes via local delivery and performed PTT for cancer ablation therapy. Finally, 
biodegradation and renal clearance were confirmed by performing whole-body PA monitoring and 
a degradation test. 
Key words: Carbon nanodot, Nitrogen doping, Photoacoustic, Photothermal, Biodegradation.  
Introduction 
There have been significant achievements in the 
development of multifunctional nanoparticles, which 
have stimulated various biomedical research areas, 
including molecular imaging, cancer therapy, and 
drug delivery [1-5]. In particular, photoactive 
nanoparticles have been widely used as diagnostic 
and therapeutic agents with laser irradiation [6, 7]. 
When photoactive nanoparticles are irradiated with 
nanosecond pulsed laser light, they heat up and 
generate acoustic waves that can be used for 
photoacoustic (PA) imaging. PA imaging is regarded 
as an emerging non-invasive imaging technique that 
provides high ultrasonic resolution and strong, 
optically sensitive images in deep tissues because of a 
laser-induced PA effect [8-10]. Because of its hybrid 
properties, the PA imaging technique provides in vivo 
deep tissue high-resolution anatomical, functional, 
and molecular images [11-19]. In another study, 
continuous-wave laser irradiation of a 
photo-activated nanoparticle-injected region was 
used to generate a temperature increase in a selected 
area; this technique was used as photothermal 
therapy (PTT) for tumor ablation. PTT has received 
attention because it facilitates selective tumor ablation 
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and minimizes damage to normal tissues [20-23]. 
Therefore, it could be advantageous to combine 
contrast agent-based PA imaging and PTT within a 
single probe for use in disease diagnosis and therapy.  
Among the various types of nanoparticles, 
metallic nanoparticles, such as gold-based 
nanostructures [2, 24-29], carbon-based nanoparticles 
[25, 30, 31], and organic nanoparticles [32-36], have 
been reported as multifunctional nanoparticles for PA 
imaging and PTT because of their strong 
photo-absorbing abilities. Unfortunately, even for the 
metallic nanoparticles that have shown excellent 
performance, their photostability, biocompatibility, 
and biodegradability remain critical issues for true 
clinical translation. For example, long-term laser 
irradiation of gold nanoparticles can cause 
morphological changes and will generally cause 
changes in the optical properties of the nanoparticles 
and reduce absorbance [37, 38]. Additionally, gold 
nanoshells coated with polyethylene glycol 5000 have 
been shown to be difficult to excrete from the body 
[39], and the use of surfactants during gold nanorod 
synthesis has been shown to cause toxicity [40, 41]. 
Thus, alternative agents with strong absorbance must 
maintain the optical stability and biodegradability of 
the nanoparticles.  
Carbon nanoparticles are regarded as being 
relatively more stable and biocompatible than are the 
nanostructures described above [42, 43]. Carbon 
nanodots (CNDs) are promising carbon-based 
imaging probes that have attracted much attention 
because of their properties, including excellent 
biocompatibility, water solubility, and photostability 
[44-51]. Recently, several studies have successfully 
demonstrated the feasibility of using CNDs as 
imaging probes [52-57], but the main challenge for 
practical applications is to guarantee 
biodegradability. Furthermore, the fundamental 
mechanism of how CNDs interact with low-energy 
photons should be studied to improve their optical 
properties related to image resolution and contrast.  
In this study, we synthesized biocompatible, 
near-infrared (NIR)-absorbing N-doped CNDs 
(N-CNDs) for PA imaging and PTT by carbonizing 
organic acids with a controllable nitrogen source. The 
synthesized N-CNDs showed excellent photostability 
and strong optical absorbance in the NIR region, 
where tissue and hemoglobin show small optical 
absorption. Thus, the PA signals from N-CNDs were 
high enough to detect inside living animals, and 
minimally invasive PTT using N-CNDs was possible. 
We performed time-resolved PA imaging of sentinel 
lymph nodes (SLNs) and assessed renal clearance 
after hypodermic injection to investigate the 
biodegradability and potential application of N-CNDs 
as a PA imaging contrast agent. Degradation and 
cytotoxic tests were also performed to further verify 
the biodegradability of N-CNDs. Finally, we treated 
the liver cancer tumor on the mouse skin using 
photothermal ablation with N-CNDs injected near the 
tumor region. 
2. Materials and Methods 
2.1 Synthesis of N-CNDs  
An aqueous solution of citric acid was prepared 
by dissolving citric acid (1 g) in water (1 mL). The 
aqueous solution of citric acid was transferred into a 
round-bottom flask containing oleylamine (1 mL) and 
octadecene (9 mL). To the mixture under vigorous 
stirring, 0, 1, 3, 5, 7, 10, 12, and 14 M (conc.) solutions 
of nitric acid (1 mL) were added for synthesizing N0-, 
N1-, N3-, N5-, N7-, N10-, N12-, and N14-CNDs, 
respectively. The mixture was then heated for 3 h at 
250°C. The resulting solution (5 mL) was mixed with 
methanol (40 mL) and then separated by 
centrifugation at 3,000 rpm for 15 min, which was 
repeated three times. After drying in a vacuum oven 
overnight, the resulting viscous liquid (50 mg) was 
re-dispersed in toluene (5 mL), and to this solution, 
ethanolamine (15 mL) was added. The mixture was 
then heated at 100°C under vigorous stirring until 
solid remained. The resulting solid was dissolved in 
water (10 mL) and then dialyzed against water three 
times (24 h for each time) using Spectra/Por Biotech 
Cellulose Ester dialysis tubes (100–500 Da). The water 
was removed from the resulting solution by 
freeze-drying. The resulting solid (N-CNDs) was 
stored in a freezer for further use. 
2.2 PA imaging system  
All in vitro, in vivo, and ex vivo PA experiments 
were conducted using an acoustic-resolution 
reflection-mode PA imaging system (Figure S1). A 
Q-switched Nd:YAG laser (SLII-10; Continuum) at 
532-nm optical wavelength was used for pumping a 
tunable OPO laser (Surelite OPOPLUS; Continuum), 
which provided a 5-ns pulse duration over the 
wavelength tuning range of 680 to 2500 nm at a 10-Hz 
repetition rate. To avoid PA signal generation from 
the surface, the irradiated laser beam had a 
donut-shaped pattern achieved by passing through a 
conical lens and an optical condenser. The pulsed 
laser energy was ~5 mJ/cm2, which is much less than 
the American National Standards Institute standard 
limit (~20 mJ/cm2). A wavelength of 680 nm was used 
for in vivo PA imaging. A spherically focused 
ultrasonic transducer with a 5-MHz center frequency 
(V308; Olympus NDT) was applied for detecting the 
generated PA signals. A pulser/receiver (5072PR, 
Olympus NDT) and a digital oscilloscope (MSO 5204; 
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Tektronix) were used for amplifying the PA signal 
and recoding, respectively. Two linear scanners were 
used to perform raster scanning to obtain volumetric 
PA imaging. To improve the acoustic coupling 
efficiency, a homemade water tank and ultrasound 
gel were used. The animals were then placed on a 
sample stage for SLN and bladder imaging. The 
5-MHz ultrasonic transducer induced axial and lateral 
resolutions of 145 and 950 μm, respectively. It takes 
approximately 30 mins to acquire one 
three-dimensional PA image. 
2.3 In vitro/in vivo/ex vivo PA imaging setup  
To measure the in vitro PA sensitivity and 
spectrum of N-CNDs, eight silicon tubes were 
prepared with a N0-, N1-, N3-, N5-, N7-, N10-, N12-, 
and N14-CNDs at the same concentration (20 
mg/mL) by tuning the laser wavelength from 680 to 
950 nm. Moreover, to compare the PA amplitude of 
N-CNDs with those of conventional materials at the 
same optical density of 0.6 mm-1, we measured the PA 
signal amplitudes of three silicon tubes containing 
gold nanorod (GNR), methylene blue (MB), and 
N-CNDs under 680-nm pulsed laser excitation. 
Furthermore, to investigate the stability of the PA 
response, GNR, MB, and N-CNDs (20 mg/mL) were 
also compared by monitoring the PA amplitudes 
during 1,100 pulsed laser shots of 15 mJ/cm2.  
We satisfied the guidelines of the university on 
the care and utilization of laboratory animals in all 
animal experiments. For in vivo and ex vivo SLN PA 
imaging, female Sprague-Dawley rats (weight: ~250 
g) were fully anesthetized by using a 
vaporized-isoflurane system. After removing the hair 
of the left-side axillae, the rat was placed on the 
sample stage. The left-side axillae vasculature 
networks and lymphatic system of the rats before and 
after hypodermic injection of N-CNDs (0.1 mL, 20 
mg/mL) (n = 3) were photoacoustically visualized. 
After completing in vivo PA imaging, we performed 
validation by performing ex vivo PA imaging of 
extracted lymph nodes. For in vivo whole-body PA 
imaging, female Balb/c nu/nu mice (Weight: ~20 g) 
were prepared under full anesthetization. After 
obtaining control whole-body PA images of the 
abdomen side with an invisible bladder, the N-CNDs 
(0.1 mL, 20 mg/mL) (n = 3) were subcutaneously 
delivered into the left leg. Then, we photoacoustically 
monitored the visualization of the bladder over 280 
min. 
2.4 PTT materials  
Dulbecco’s modified Eagle’s medium (DMEM), 
fetal bovine serum (FBS), antibiotics, and 
phosphate-buffered solution (PBS) were purchased 
from Invitrogen (Carlsbad, CA). 3-(4,5-Dimethyl-2- 
thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide 
(MTT) was supplied from Sigma-Aldrich (St. Louis, 
MO). Calcein-AM and propidium iodide (PI) were 
obtained from AnaSpec (Fremont, CA). The 
8-chamber glass slides with polystyrene vessels were 
purchased from BD Falcon (Franklin Lakes, NJ). 
2.5 Photothermal performance of N-CNDs  
N-CNDs were dissolved in PBS at different 
concentrations (0 mg/mL to 20 mg/mL). Each 
N-CNDs solution (1 mL) was introduced in a quartz 
cuvette and irradiated with 808-nm laser light at a 
power density of 2 W/cm2 for 10 min. To observe the 
photothermal characteristics of N-CNDs, a 
thermocouple probe was inserted into the cuvette to 
contact the N-CNDs solution, and the temperature 
was recorded every 30 s. PBS was used as a negative 
control. 
2.6 Confocal microscopy for cellular uptake  
Normal mouse liver hepatocyte cells (FL83B) 
and human liver cancer cells (HepG2) were cultured 
in high-glucose DMEM supplemented with 10 vol% 
of FBS at 37°C in an incubator. The cells were seeded 
in the 8-chamber confocal slide at a density of 4 × 104 
cells/well and incubated for a day. Then, N-CNDs 
solutions (10 mg/mL) in 200 μL of DMEM were 
added to the wells. The cellular uptake of N-CNDs 
was assessed by confocal microscopy. The emission 
light of N-CNDs was spectrally resolved into four 
channels. We observed strong blue, green, and yellow 
fluorescence from N-CNDs-labeled cells depending 
on the excitation wavelength, and less fluorescence 
was observed from the control group. 
2.7 Cytotoxic test  
FL83B cells and HepG2 cells were seeded in a 
96-well plate at 1 × 104 cells/well and cultured in a 
humidified 5% CO2 incubator at 37°C for 24 h. 
N-CNDs were dissolved in a cell culture medium 
containing 10 vol% FBS and 1 wt% of antibiotics. The 
cells were allowed to incubate with different 
concentrations of N-CNDs (0, 0.1, 0.25, 0.5, 1, 2.5, 5, 
and 10 mg/mL) for another 24 h at 37°C, respectively. 
After the cells were washed twice with PBS, the cell 
culture medium was changed. The relative cell 
viability was measured by MTT assay (n = 3). The 
absorbance was measured at 540 nm. 
2.8 Photothermal effect of N-CNDs in vitro  
HepG2 cells at a density of 1 × 104 were seeded 
onto 96-well plates. After incubation for 24 h, the cells 
were treated with different concentrations of N-CNDs 
(0, 0.1, 1, and 10 mg/mL) for 1 hour. After 10-min 
exposure of 808-nm light at 2 W/cm2, the cells were 
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allowed to incubate for an additional 4 h. Cells treated 
without laser were used as a control group. To assess 
the photothermal effect of N-CNDs on the cells with 
and without exposure to NIR laser irradiation, the 
phototoxicity was measured by MTT assay (n = 3). To 
further evaluate the efficacy of PTT, HepG2 cells at a 
density of 3 × 104 were incubated with and without 
N-CNDs (10 mg/mL) for 12 h and then irradiated 
with 808-nm laser light (2 W/cm2) for 10 min. After 
another incubation for 2 h, the cells were washed with 
PBS, stained with calcein-AM and PI, and then 
imaged by Leica TCS SP5II MP SMD FLIM (Leica, 
Deerfield, IL). The excitation laser was tuned to 488 
and 594 nm. 
2.9 Photothermal effect of N-CNDs in vivo  
Animal experiments were approved by the 
university in compliance with the regulations 
concerning experimental animals. To assess the 
therapeutic efficacy of N-CNDs, cancer model mice 
were prepared by inoculation with HepG2 cells at a 
density of 1 × 107 to the left and right flanks of female 
Balb/c nude mice (5 weeks old, 20–25 g) and allowed 
to grow for 3–5 days until the tumor volume reached 
approximately 27 mm3 (n = 5). The tumor was treated 
by intratumoral injection of the solutions of PBS and 
N-CNDs (100 μL, 20 mg/mL) through a 26-gauge 
needle. The right tumors only were irradiated with 
808-nm laser light (2 W/cm2) for 10 min. The left 
tumors without laser treatment were used as the 
control group. The tumor sizes were monitored by 
measuring the tumor diameters with a caliper. The 
tumor volume was determined according to the 
following equation:  
V= (A × B2)/2 
where A and B are the maximum and minimum 
diameter of the tumor [58]. The temperature change in 
the tumor region was monitored by a thermal camera 
for different groups. To evaluate the therapeutic 
efficacy of PTT, tumor tissues were harvested and 
fixed in 4% formaldehyde solution, embedded in 
paraffin blocks, sectioned into 5-μm slices, and 
mounted on glass slides. After H&E staining, the 
sections were observed by using an optical 
microscope (20× objectives). 
2.10 Degradation test  
Degradation of N-CNDs was investigated by 
using UV/Vis absorbance. A 1-mL aliquot of N-CNDs 
(2 mg/mL in PBS, pH = 7.4) was added to 1 mL of 
H2O2 solution (200 mM or 2 M) or serum and 
incubated at 37ºC. The aliquot was collected at each 
time point and kept in the deep freezer. The 
absorption was measured at 450 nm (n = 3). 
2.11 Toxicity test in vivo  
Eight white Balb/c mice were intravenously 
injected with 100 μL of 20 mg/mL N-CNDs (a dose of 
100 mg/kg). The other four mice were used as the 
controls. The mice were sacrificed to collect the major 
organs and blood for histological and blood analyses 
at 7 and 28 days post-injection of N-CNDs. Major 
organs (heart, lung, liver, kidney, spleen) were fixed 
in 10% formalin, embedded in paraffin, sectioned, and 
stained with H&E. The serum chemistry and complete 
blood panel were measured at the Center for 
Evaluation of Biomaterials. 
3. Results 
3.1. Synthesis of N-CNDs and effect of 
N-doping 
N-CNDs were synthesized by performing 
solvothermal carbonization of citric acid in the 
presence of nitric acid as an N source (Figure 1a). 
Briefly, an aqueous solution of citric acid with nitric 
acid was heated at 250 °C to be initially dehydrated to 
form polymer-like intermediates. These intermediates 
were then carbonized to form carbogenic cores, and 
simultaneously, oleylamine was grafted onto the 
surface of the core through amidation to suppress 
undesired inter-particle agglomeration during 
carbonization. Grafted oleylamine was subsequently 
replaced by ethanolamine to endow our N-CNDs 
with water solubility (Figure S2). We controlled the N 
content of N-CNDs by varying the molarities of nitric 
acid solutions, and N-CNDs prepared with 0, 1, 3, 5, 7, 
10, 12, and 14 M (conc.) nitric acid solutions were 
coded as N0-, N1-, N3-, N5-, N7-, N10-, N12-, and 
N14-CNDs, respectively. Transmission electron 
microscopy showed that the N-CNDs were well 
dispersed with a particle size of ~3 nm (Figure 1b). 
Previously, nanostructures in this size range have 
been shown to be readily excreted via renal clearance 
[59]. Figure 1c shows partial graphitic structures or 
graphitic “clusters” (a few angstroms in size) that 
were found in the core of N-CNDs after 
low-temperature (~300°C) carbonization. These 
graphitic clusters provide π electrons that would 
contribute to the formation of the highest occupied 
molecular orbital (HOMO) and lowest unoccupied 
molecular orbital (LUMO) levels. X-ray photoelectron 
spectroscopy data showed that our N-CNDs 
contained a significant amount of N atoms that 
primarily originated from nitric acid and partially 
surface amide groups formed by ethanolamine, and 
their N content varied with the molar concentration of 
nitric acid (Figure S3). The N atoms that had lone 
pairs of electrons (or non-bonding orbitals) generated 
electronic states in between the HOMO and LUMO 
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levels or the so-called intra-gap states, such as 
non-bonding (n) or defective states. Because intra-gap 
states reduce the energy gap, as illustrated in Figure 
1d. N-CNDs that have more N atoms can generally 
absorb more photons of lower energy; however, the 
absorbance values of N-CNDs were saturated at the N 
content higher than N7 (Figure 1e). Consistently, 
photoluminescence spectroscopy of N-CNDs shows 
that a secondary peak is developed at around 500 nm 
as the N content increases, which also strongly 
suggests the formation of the N-induced intra-gap 
states (Figure S4). These intra-gap states have a major 
role in generating phonons (heat) through 
Shockley–Read–Hall (SRH) electron-hole 
recombination or other defect-related paths. Figure 1f 
indicates the PA spectrum at different nitrogen atoms. 
N7-CNDs showed the highest PA signal amplitude, 
which shows a trend similar to that of light 
absorption. Generally, PA signal amplitude is linearly 
proportional to absorbance, as shown in Equation 1.  
     (1) 
Where Г indicates the Gruneisen parameter, µa  
indicates the optical absorption coefficient, and F 
indicates the laser fluence. Figure S5 shows that 
N-CNDs with more N atoms raised the surrounding 
temperature faster under NIR (λ = 680−808 nm) laser 
excitation. For instance, under λ = 808 nm excitation, 
N7-CNDs raised temperatures 20 times faster than 
did N0-CNDs and four times faster than did N1-CND. 
The temperature is raised faster because more 
nitrogen atoms generate more intra-gap states to 
facilitate carrier trapping from the LUMO to an 
intra-gap state and carrier relaxation between 
intra-gap states. We also detected photons of nearly 
half-gap energy (λ = 900–1200 nm) that were emitted 
in the final stage of SRH recombination (Figure S6), 
which directly proves the existence of intra-gap states 
in our N-CNDs. Because the quantum yield (Ф) of 
N-CNDs in the range of 900–1500 nm under 808-nm 
laser excitation was ~1% (Figure S6), it could be 
calculated according to Equation 2, which shows that 
99% of excited-state electrons were thermally 
dissipated through SRH recombination: 
             (2) 
where kr indicates the radiative decay rate and knr 
indicates the non-radiative decay rate. 
 
 
Figure 1. Synthesis of N-CNDs and effect of nitrogen doping. (a) Synthesis of N-CNDs. (b) TEM image of N-CNDs (scale bar = 5 nm). (c) Partial graphitic 
structures in the core of N-CNDs (scale bar = 2 nm). (d) Illustration of electronic structures and nitrogen-induced intra-gap states of N-CNDs. (e) Optical absorption 
spectrum of N-CNDs as a function of nitric acid concentration. (f) PA amplitude spectrum with different N-doped CNDs. HOMO, highest occupied molecular 
orbital; LUMO, lowest unoccupied molecular orbital.  
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Figure 2. Photoacoustic (PA) and photothermal characteristics of N-CNDs. (a) PA signal amplitude comparison of GNR, MB, and N-CNDs at the same 
optical density. (b) The stability of the PA responses of GNR, MB, and N-CNDs depending on the number of pulses of laser irradiation. (c) Optical absorption 
measurement of GNR and N-CNDs with and without laser irradiation. (d) Temperature elevation curves of N-CNDs at different concentrations (0, 0.1, 0.25, 0.5, 1, 
2.5, 5, 10, 20 mg/mL). GNR, gold nanorod; MB, methylene blue.  
 
3.2 PA and photothermal characteristics of 
N-CNDs 
The optical absorbance of N-CNDs increased 
with increasing concentration (Figure S7a), which 
indicated that N-CNDs have broad absorption in the 
NIR region (680–800 nm) and were well matched to 
the PA amplitude spectral distribution at the same 
concentration (Figure S7b). Although PA signal 
amplitude decreased with increasing wavelength, the 
PA signal could still be detected at 900 nm. The PA 
sensitivity at 680 nm was measured by testing the PA 
signal amplitude of N-CNDs at different 
concentrations; this measurement showed a linear 
relationship. The detection limit of the N-CNDs was 1 
mg/mL (Figure S8). To investigate the performance of 
N-CNDs as a contrast agent, we directly compared 
the PA signals with those of popular conventional PA 
contrast agents, such as GNR and MB (Figure S9). At 
the same optical density, the normalized PA signal 
amplitude of N-CNDs (2.2 ± 0.2) was approximately 
two times higher than those of GNR (1.0 ± 0.1) and 
MB (1.3 ± 0.1) (Figure 2a). This result implies that 
N-CNDs have higher heat conversion efficiency than 
those of GNR and MB at the same optical density, 
which contains strong nonradiative energy decay, 
high heat conductance and capacity, and weak optical 
scattering [19, 60]. In addition, N-CNDs showed 
strong stability of the PA response to high-energy 
pulsed laser irradiation (Figure 2b). Pulsed laser at a 
680-nm optical wavelength (15 mJ/cm2) was projected 
onto the samples. The PA signal amplitudes of 
N-CNDs and MB were relatively stable, but the PA 
signals from GNR decreased by 50% during the 300 
pulses and entered the photobleaching state. 
Furthermore, the optical stability of N-CNDs for PTT 
was assessed by comparing GNR (Figure 2c). The 
optical absorption of N-CNDs varied from 0.43 to 
0.40, whereas GNR varied from 0.39 to 0.28 under 
660-nm continuous wave laser excitation over 10 min. 
To examine the photothermal properties of CNDs, the 
temperature changes of an aqueous solution of CNDs 
at diverse concentrations (0.1–20 mg/mL) were 
measured under irradiation by a 808-nm NIR laser (2 
W/cm2), and DI water was used as the control (Figure 
2d). 
3.3 In vivo/ex vivo PA sentinel lymph node 
mapping 
 SLNs and vascular networks were 
photoacoustically visualized using an 
acoustic-resolution reflection-mode PA imaging 
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system at 680-nm optical wavelength (Figure S1). 
Detecting SLNs is a clinically important issue for the 
diagnosis of metastatic cancer [13]. Figures 3a–c show 
the PA maximum amplitude projection (MAP) 
images, which clearly indicate the position of 
N-CNDs draining from an SLN. Figures 3e–g show 
the depth-resolved cross-sectional PA images of the 
corresponding yellow line in Figures 3a–c, 
respectively. Additionally, the depth information of 
the PA MAP image (Figure 3b) was encoded by a 
pseudo color, as shown in Figure 3d. Normally, the 
SLNs are located ~3 mm below the skin surface. 
Before injecting N-CNDs, the PA MAP image did not 
delineate the SLN but only showed the vasculature. 
After intradermal injection of N-CNDs, the PA signal 
amplitude of the SLN suddenly increased at 30 mins 
(167.2 ± 21.9%); subsequently, it decreased 
continuously until 180 min (33.1 ± 9.9%) (n = 3, Figure 
3h). These results indicate that N-CNDs were initially 
collected and then eliminated from the SLN after 
circulating in the lymphatic system. To validate the 
results of the in vivo PA imaging, ex vivo PA imaging 
was performed by excising lymph nodes containing 
N-CNDs and normal lymph nodes from the axial 
region of rats (Figure 3i). Only the excised lymph 
nodes containing N-CNDs were detected in the PA 
MAP images (Figure 3j), whereas normal ones did not 
appear photoacoustically. Normally, the highest PA 
signal was measured from the SLN. However, an SLN 
injected with N-CNDs did not show the highest PA 
signal because the N-CNDs degraded. As the 
N-CNDs were fading away from the SLN, the 
strongest PA signal was observed at L2 (second 
lymph node). The PA contrast of the SLN and L2 were 
determined to be 299 ± 86% and 512 ± 65%, 
respectively (Figure 3k). Therefore, these results 
demonstrate the potential usefulness of N-CNDs for 
PA lymphoscintigraphy in clinical axillary staging of 
cancer. 
 
 
Figure 3. In vivo photoacoustic (PA) sentinel lymph node (SLN) mapping with N-CNDs injection. (a) PA maximum amplitude projection (MAP) image 
before N-CNDs injection. (b) PA MAP image 30 min after N-CNDs injection. (c) PA MAP image after 150 min of N-CNDs injection. (d) Depth-encoded PA MAP 
image after 30 min of N-CNDs injection. (e-g) Corresponding PA B-mode images of the dashed line area in (a–c). (h) PA signal profile in the SLN region from before 
injection to 180 min after the N-CNDs injection. (i) and (j) Photograph and PA MAP image, respectively, of SLNs excised after the N-CNDs injection (L1–L3) and 
control (L4–L6). (k) PA signal of the excised SLNs. SLN, sentinel lymph node; L, lymph node. 
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Figure 4. In vivo photoacoustic (PA) bladder imaging and degradation test using N-CNDs. (a) Coronal (front) PA maximum amplitude projection (MAP) 
image before N-CNDs injection. (b) and (c) Coronal PA MAP image after 100 min and 450 min of N-CNDs injection. (d–f) Corresponding PA B-mode images at the 
dashed line region of (a–c). (g–i) Corresponding depth-encoded PA MAP images of the PA MAP images of (a–c). (j) and (k) PA signal profile in the bladder region 
(white dashed circle in (a–c)) and injected area (red dashed circle in (a–c)) from before injection to 500 min after the N-CNDs injection. (l) and (m) Serum 
biochemistry assay of N-CNDs-injected mice.  
 
3.4 In vivo whole-body PA imaging of renal 
clearance of N-CNDs  
After subcutaneous injection of N-CNDs, 
whole-body PA imaging was performed to determine 
the bodily distribution and clearance of N-CNDs. 
Figures 4a–c and Figures 4d–f present the whole-body 
PA MAP images and depth-resolved cross-sectional 
PA images of the yellow line, respectively. Although 
the blood vessels are clearly shown in the control PA 
images (Figs. 4a and d), the bladder was invisible 
because of its transparency. Figures 4g–i show the 
depth-coded PA MAP images corresponding to 
Figures 4a–c, respectively. At 100 min post-injection of 
N-CNDs, an increased PA signal appeared in the 
bladder (Figs. 4b and 4e). Over time, the PA signal 
amplitude of the bladder was generally enhanced up 
to 450 min (1314 ± 237%) (n = 3, Figure 4j). However, 
the PA signal amplitude of the injection area 
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decreased up to 500 min (124 ± 55 %) (n = 3, Figure 
4k). These PA experimental results revealed that 
N-CNDs could be removed from the body by renal 
clearance after subcutaneous injection. The results 
showed that N-CNDs can contribute to the diagnosis 
of urinary tract diseases, including leaks and fistulas 
[61]. 
3.5 Degradation and in vivo toxicity  
N-CNDs degradation was investigated using 
UV/Vis absorbance (Figs. 4l and m). Upon exposure 
to H2O2, the formation rate of hydroxyl radials 
increased in two ways: reduction of H2O2 at the 
conduction band and self-decomposition by 
irradiation. The former caused degradation of 
N-CNDs. As seen in Figure 4l, the decolorization rate 
increased when the H2O2 concentration increased 
from 0 to 1 M. The toxicity of N-CNDs was 
investigated in vivo. We monitored the behaviors of 
mice after intravenous injection of N-CNDs (100 
mg/kg), and no apparent symptoms of toxic effects 
were observed within 1 month. The mice were 
sacrificed at days 7 and 30 for careful necropsy, and 
PBS treated mice were used as controls. The mice 
hearts, lungs, livers, kidneys, and spleens were fixed, 
sliced, and stained by hematoxylin and eosin (H&E) 
(Figure S10). Because of the high renal clearance rate 
of N-CNDs in the body, no noticeable organ 
destruction or inflammatory lesions were observed in 
the hearts, lungs, livers, kidneys, and spleens of the 
mice at 7 and 30 days, similar to the control group 
results. To further investigate the potential toxicology 
of N-CNDs in the body, a complete blood panel test 
and serum biochemistry assay were performed on 
N-CNDs-injected (100 mg/kg) white Balb/c mice at 
days 7 and 30. The measured parameter results were 
within normal ranges (Figure S11). The toxicity test 
results indicated that N-CNDs were biocompatible in 
vivo in mice for at least 30 days at our tested dose. 
3.6 In vitro/in vivo PTT using N-CNDs  
We investigated the in vitro cytotoxicity of 
N-CNDs and PTT efficacy in FL83B and HepG2. A 
high concentration (10 mg/mL) of N-CNDs caused no 
cytotoxicity in FL83B cells or HepG2 cells without 
laser irradiation (Figure S12a). In contrast, with 
808-nm NIR laser irradiation, the viabilities of HepG2 
cells decreased significantly as the concentration of 
N-CNDs increased (Figure S12b). Subsequently, a 
live/dead assay was performed to further verify the 
PTT efficacy of N-CNDs. Figure S12c shows that the 
cells incubated with N-CNDs and exposed to 808-nm 
laser light (2 W/cm2, 10 min) exhibited red 
fluorescence, which indicated cancer cell death. 
Figure S12d shows confocal images of FL83B cells and 
HepG2 cells treated with N-CNDs at excitation 
wavelengths of 405, 488, 561, and 633 nm. In the 
control group, all cells lived, as indicated by the green 
fluorescence. Based on the in vitro results, we further 
investigated the in vivo PTT of cancers using N-CNDs. 
Balb/c nude xenograft HepG2 tumor model mice 
(five mice per group) with a tumor volume of 27 mm3 
were intratumorally injected with N-CNDs solution 
(20 mg/mL, 100 μL) and PBS as a control. The tumor 
regions of the PBS + laser group and N-CNDs + laser 
group were irradiated with the laser for 10 min, 
whereas the laser-untreated group was not irradiated 
for comparison. The temperature of the tumor area 
was monitored by a thermal camera at specific time 
points (Figures 5a and b). Under NIR laser irradiation, 
the tumor surface temperature of the N-CNDs + laser 
group rapidly increased from ~27°C to 50°C. The 
temperature change causes hyperthermia that can kill 
cancer cells. In contrast, the temperature of the tumor 
region of the control group and non-irradiated 
surrounding normal tissues showed no temperature 
change. To confirm the PTT efficacy of the N-CNDs, 
we monitored the tumor growth rates. After 
treatment with PBS regardless of laser irradiation, the 
tumor only continued to grow. Also, the tumor 
treated with N-CNDs without laser irradiation, the 
tumor volume increased over time. However, the 
tumor that was treated with N-CNDs and 808-nm 
NIR laser irradiation together completely disappeared 
(Figs. 5c and d). The anti-tumor effect was assessed by 
histological analysis of tumor tissues by H&E staining 
and TUNEL assay 12 hours after laser irradiation. The 
tumor tissues treated with N-CNDs + laser irradiation 
showed extensive nuclear shrinkage and 
fragmentation, which suggested that the PTT was 
enhanced in vivo. In contrast, cell destruction was 
negligible in tumor tissues treated with PBS, PBS + 
laser irradiation, and N-CNDs. From the fluorescence 
TUNEL assay (Figure 5e), the tumor tissues treated 
with N-CNDs + laser irradiation showed green 
fluorescence, which indicated cellular apoptosis. 
Normal areas stained blue, and TUNEL-positive areas 
stained green. In contrast, the tumor sections treated 
with PBS, N-CNDs, and PBS + laser irradiation 
showed only blue fluorescence. These results 
confirmed the feasibility of N-CNDs for PTT of 
cancer. 
4. Conclusion 
We successfully verified the feasibility of a 
biocompatible optical-absorbing material, N-doped 
CND, from PA imaging of SLN and bladder, and 
cancer ablation PTT. The relative PA signal increased 
in SLNs after injection of N-CNDs, and degraded after 
circulating through the lymphatic system. 
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Additionally, the PA signal in the bladder region 
increased dramatically after injection of N-CNDs, 
which indicated that N-CNDs were eliminated 
effectively in the urine. In cancer ablation PTT, the 
N-CNDs-injected region after laser irradiation 
treatment showed complete tumor ablation without 
recurrence. The light-absorbing material, N-CNDs, 
can be a promising agent for enhancement of optical 
contrast in PA imaging and to enhance the effect of 
PTT.  
 
 
Figure 5. Photothermal therapy (PTT) using N-CNDs (a) Thermal camera images of N-CNDs injection with NIR laser irradiation. (b) Temperature profile of 
the injected area with and without NIR laser irradiation. (c) and (d) PTT monitoring and tumor volume profile of PBS and N-CNDs-injected models. (e) Histological 
analysis of tumor tissues with H&E staining and TUNEL assay 12 hours after PBS and N-CNDs injection without and with NIR laser irradiation. (black scale bar = 100 
µm, white scale bar = 1000 µm). 
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